ValuEngine downgraded shares of Aethlon Medical, Inc. (OTCMKTS:AEMD) from a sell rating to a strong sell rating in a report published on Wednesday morning.
Aethlon Medical (OTCMKTS:AEMD) traded up 5.10% on Wednesday, hitting $1.03. The stock had a trading volume of 1,269,479 shares. The company has a 50-day moving average price of $1.54 and a 200 day moving average price of $1.97. The firm’s market cap is $9.16 million. Aethlon Medical has a 52-week low of $0.90 and a 52-week high of $5.18.
Aethlon Medical (OTCMKTS:AEMD) last issued its quarterly earnings data on Thursday, August 10th. The medical equipment provider reported ($0.21) EPS for the quarter, missing the consensus estimate of ($0.16) by ($0.05). Equities analysts forecast that Aethlon Medical will post ($0.50) earnings per share for the current fiscal year.
ILLEGAL ACTIVITY NOTICE: This piece was first posted by Sports Perspectives and is the sole property of of Sports Perspectives. If you are viewing this piece on another domain, it was illegally stolen and reposted in violation of US & international copyright legislation. The original version of this piece can be accessed at https://sportsperspectives.com/2017/10/12/aethlon-medical-inc-aemd-downgraded-to-strong-sell-at-valuengine.html.
Aethlon Medical Company Profile
Aethlon Medical, Inc is a medical device company focused on creating devices for cancer, infectious disease and other life-threatening conditions. The Company operates through two segments: Aethlon, which represents its therapeutic business activities, and ESI, which represents its diagnostic business activities.
Receive News & Ratings for Aethlon Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aethlon Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.